Related Experiment Video
Updated: Jan 31, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction
Richard Armstrong1, Giovanni Luigi De Maria2, Roberto Scarsini2
1a Department of Cardiology , St James's Hospital , Dublin , Ireland.
Insights
Assessing and managing microvascular dysfunction after ST-segment elevation myocardial infarction (STEMI) is crucial for long-term outcomes. This review covers current evidence and strategies for prevention and treatment to improve patient prognosis.
Area of Science:
- Cardiology
- Cardiovascular Research
- Interventional Cardiology
Background:
- Microvascular dysfunction in ST-segment elevation myocardial infarction (STEMI) correlates with poor prognosis.
- Early assessment and intervention can improve outcomes post-primary percutaneous intervention.
- Coronary microcirculatory impairment is a significant concern in STEMI patients.
Purpose of the Study:
- To comprehensively review evidence on assessing and managing coronary microcirculatory injury/dysfunction in STEMI.
- To explore strategies for applying existing and novel therapies for microvascular impairment.
- To guide clinical practice in preventing and treating microvascular dysfunction.
Main Methods:
- Review of existing literature on microvascular dysfunction in STEMI.
- Analysis of non-invasive and invasive assessment methods.
- Evaluation of pharmacological and mechanical therapeutic strategies.
Main Results:
- Multiple methods exist for assessing microvascular dysfunction, including invasive physiological measurements with prognostic value.
- Various therapeutic options, both pharmacological and mechanical, are available for prevention and treatment.
- Current guidelines lack a clear algorithm for applying these therapies.
Conclusions:
- Effective assessment of microvascular dysfunction is possible using established methods.
- Therapeutic strategies for microvascular dysfunction exist but require better clinical guidance.
- Future research should focus on physiology-guided therapies to identify high-risk STEMI patients benefiting from intervention.
Introduction:
Microvascular dysfunction in the setting of acute ST-segment elevation myocardial infarction (STEMI) is an indicator of poor long-term prognosis. Prompt assessment and pharmacological or procedural therapy (prophylactic or post onset of dysfunction) may improve outcomes in STEMI post-primary percutaneous intervention. Areas covered: The aim of this review is to provide a comprehensive analysis of the evidence available about the assessment and management of coronary microcirculatory injury/dysfunction in STEMI. We also aim to elucidate the possible strategies that could be applied in clinical practice to support the application of already available or novel therapeutic strategies for the prevention and management of microvascular impairment. Expert commentary: There are multiple established methods in assessing microvascular dysfunction, both non-invasively and invasively. Invasive physiological measurements allow real-time assessment of microvascular dysfunction and have prognostic cut-off values. Multiple therapeutic modalities exist for both preventing and treating microvascular dysfunction. These can be either pharmacological or mechanical, and there is no algorithm to guide if, how and when to apply them. Future research into both procedural and pharmacological therapy guided by physiological measurements is needed, with the aim of recognizing high-risk patients who would benefit from therapy.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management

